MEDU-36. MERIVA® AND A NOVEL CHEMICALLY-MODIFIED CURCUMIN FOR THE TREATMENT OF MEDULLOBLASTOMA

Medulloblastoma is the most common pediatric central nervous system cancer, and despite an overall favorable prognosis with intensive multimodal treatment, children are especially at risk for significant negative effects of these treatments. There is a need for treatments that are less toxic with fe...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Wright, Avery, Stuart, Benjamin, Ruggieri, Rosamaria, Chakraborty, Shamik, Kelley, Kevin, Wechsler-Reya, Robert, Johnson, Francis, Golub, Lorne, Scaduto, Joseph, Symons, Marc
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2017
Gaiak:
Abstracts
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5475164/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox083.186
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak